1Q'25 LTM Run-Rate Adj. EBITDA $5.78B
Company: CoreWeave
The claim, verbatim
CoreWeave presents a 1Q'25 LTM Run-Rate Adjusted EBITDA of $5,777 million. This figure combines $1,721 million of LTM Adjusted EBITDA with $4,056 million of estimated run-rate profits, which the company expects to earn from contracts within 24 months of signing, plus estimated Core Scientific cost savings.
Source (primary)
coreweave 8-K exhibit (d867513dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-10-09)Live source ↗
Quote: “1Q'25 LTM Run-Rate Adj. EBITDA $5,777 ... Includes Q1'25 LTM Adj. EBITDA of $1,721 million and $4,056 million of reasonably estimated identifiable "run-rate" profits (calculated on a pre-tax basis) projected to be earned from contracts within 24 months of the entry into such contracts”
How we checked this
Checked on October 13, 2026. The cited source supports every part of this claim.
The table states the $5,777 million figure. Footnote 5 lists its components: LTM Adjusted EBITDA, contract run-rate profits, and estimated Core Scientific cost savings.
Confirmed in the source:
- 1Q'25 LTM Run-Rate Adjusted EBITDA is $5,777 million
- It includes $1,721 million of Q1'25 LTM Adjusted EBITDA
- It includes $4,056 million of estimated run-rate profits projected to be earned from contracts within 24 months of entering them
- It includes estimated cost savings related to the Core Scientific acquisition
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1769628/000119312525161520/d867513dex992.htm) in full (14,931 characters, retrieved October 9, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms coreweave 8-K exhibit (d867513dex992.htm)
Quote: “1Q'25 LTM Run-Rate Adj. EBITDA $5,777 ... Includes Q1'25 LTM Adj. EBITDA of $1,721 million and $4,056 million of reasonably estimated identifiable "run-rate" profits (calculated on a pre-tax basis) projected to be earned from contracts within 24 months of the entry into such contracts”